Operating companyPharmaceuticals

Bellicum Pharmaceuticals, Inc

Houston, TX

$116.9M

sold in all offerings

Bellicum Pharmaceuticals, Inc is a corporation based in Houston, TX in the Pharmaceuticals industry group. From March 31, 2009 to September 3, 2014 it filed 6 private fundraising filings for 5 offerings and reported $117 million sold in all.

Updated November 11, 2026 · newest filing Sep 3, 2014

Amount sold

$116.9M

All offerings, newest filing of each

Offered

$136.4M

Total amount sought

Offerings

5

6 filings with amendments

Newest offering

$94.4M

Sold, first filed Sep 3, 2014

Investors

76

In the newest offering

Min. investment

-

In the newest offering

Facts

Type
Corporation
Place
Houston, TX
Industry group
Pharmaceuticals
Listed
No
First filing
March 31, 2009
Newest filing
September 3, 2014
Exemptions
506(b), 506

Amount sold by year

Each offering in the year of its first filing, at its newest amount sold

Amount sold by year

Offerings

5 offerings, newest first, each at its newest filing

First filedAmount soldOfferedInvestorsMin. investmentExemptionsSecurities
Sep 3, 2014$94.4M$94.4M76-506(b)Equity, Options or warrants, Securities on exercise of options
Mar 22, 2012$19.6M$35.0M21$1.0M506(b)Equity
Oct 25, 2010$1.2M$3.0M10$25K506Debt, Options or warrants
Oct 21, 2009$1.3M$2.5M17$25K506Debt
Mar 31, 2009$500K$1.5M11$11K506Equity

Filing history

6 filings, newest first. An amendment updates an earlier offering.

FiledKindAmount soldOfferedInvestors
Sep 3, 2014New offering$94.4M$94.4M76
Oct 16, 2013Amendment$19.6M$35.0M21
Mar 22, 2012New offering$19.9M$25.0M21
Oct 25, 2010New offering$1.2M$3.0M10
Oct 21, 2009New offering$1.3M$2.5M17
Mar 31, 2009New offering$500K$1.5M11

Related pages

Questions and answers

How much has Bellicum Pharmaceuticals, Inc raised in private offerings?

$117 million sold in 5 private offerings reported from Mar 31, 2009 to Sep 3, 2014, counting each offering once at its newest filing.

When did Bellicum Pharmaceuticals, Inc last file about a private offering?

September 3, 2014. Its newest offering reported $94.4 million sold of $94.4 million offered to 76 investors.

Which exemption does Bellicum Pharmaceuticals, Inc use?

506(b), 506. Rule 506(b) does not allow public advertising.

Is Bellicum Pharmaceuticals, Inc a listed company?

No ticker is linked to this issuer, so it is private or no longer listed.

These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.

More: Private Fundraising · Stock Screener · Industries

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube